PACB Jun 2024 14.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

4.7000

0.0000

(0.00%)

As of 10:45AM EDT. Market open.

Loading interactive chart...

PR Newswire
PacBio Announces First Quarter 2024 Financial Results
PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2024.
Zacks
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
Zacks
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
Pacific Biosciences (PACB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.